EP2710137
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.3.2012:
19.9.2018:
12755115.8
:
8.3.2032
:
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
9.3.2012
19.9.2018
:
Provectus Pharmatech, Inc.:
10025 Investment Drive, Suite 250, 37932, Knoxville, Tennessee, US
:
Pfizer Inc.:
235 East 42nd Street, 10017, New York, NY, US
:
EAGLE, Craig J.:
New York, NY, US
:
DEES, H. Craig:
Knoxville, TN, US
:
WACHTER, Eric A.:
Oak Ridge Tennessee, US
:
SINGER, Jamie:
KnoxvilleTennessee, US
:
201161451395 P:
10.3.2011:
US
:
US2012028412:
9.3.2012
:
A61K 31/352, A61K 39/395, A61P 35/00